Works matching IS 14741776 AND DT 2005 AND VI 4 AND IP 4

Results: 17

Industry shrugs off NIH consulting ban.

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 268, doi. 10.1038/nrd1690

By:

Ratner, Mark

Publication type:

Article

Chemistry-to-gene screens in Caenorhabditis elegans.

Published in:

2005

By:

Jones, Andrew K;
Buckingham, Steven D;
Sattelle, David B

Publication type:

journal article

From the analyst's couch: BioPharma licensing and M&A trends.

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 273, doi. 10.1038/nrd1697

By:

Pavlou, Alex K.;
Belsey, Mark J.

Publication type:

Article

Cellular processing of platinum anticancer drugs.

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 307, doi. 10.1038/nrd1691

By:

Wang, Dong;
Lippard, Stephen J.

Publication type:

Article

Model organisms: Chemistry-to-gene screens in Caenorhabditis elegans.

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 321, doi. 10.1038/nrd1692

By:

Jones, Andrew K.;
Buckingham, Steven D.;
Sattelle, David B.

Publication type:

Article

Osteoarthritis-an untreatable disease?

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 331, doi. 10.1038/nrd1693

By:

Wieland, Heike A.;
Michaelis, Martin;
Kirschbaum, Bernhard J.;
Rudolphi, Karl A.

Publication type:

Article

The evolving field of biodefence: therapeutic developments and diagnostics.

Published in:

2005

By:

Burnett, James C.;
Henchal, Erik A.;
Schmaljohn, Alan L.;
Bavari, Sina

Publication type:

journal article

Protein drug stability: a formulation challenge.

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 298, doi. 10.1038/nrd1695

By:

Frokjaer, Sven;
Otzen, Daniel E.

Publication type:

Article

Innovation: How molecular profiling could revolutionize drug discovery.

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 345, doi. 10.1038/nrd1696

By:

Stoughton, Roland B.;
Friend, Stephen H.

Publication type:

Article

Fresh from the pipeline: Azacitidine.

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 275, doi. 10.1038/nrd1698

By:

Issa, Jean-Pierre J.;
Kantarjian, Hagop M.;
Kirkpatrick, Peter

Publication type:

Article

G-protein-coupled receptors: Setting traps for drug discovery.

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 280, doi. 10.1038/nrd1701

By:

Ellis, Clare

Publication type:

Article

Games without frontiers.

Published in:: 2005
Publication type:: Editorial

Nuclear receptors: Choosing the right path.

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 278, doi. 10.1038/nrd1702

By:

Owens, Joanna

Publication type:

Article

Screening: Hitting the hot spots.

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 278, doi. 10.1038/nrd1705

By:

Kirkpatrick, Peter

Publication type:

Article

In Brief.

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 280, doi. 10.1038/nrd1706

By:

Ellis, Clare

Publication type:

Article

Antiviral drugs: Salubrious inhibition.

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 277, doi. 10.1038/nrd1703

By:

Jones, Daniel

Publication type:

Article

Kinase inhibitors: Surveying the kinome.

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 4, p. 279, doi. 10.1038/nrd1704

By:

Brazil, Melanie

Publication type:

Article